|
KMID : 0365420100290010012
|
|
Journal of the KLIMA
2010 Volume.29 No. 1 p.12 ~ p.15
|
|
|
Review of chronic obstructive pulmonary disease (COPD) in terms of insurance medicine
|
|
Lee Sin-Hyung
|
|
|
Abstract
|
|
|
|
Global prevalence of chronic obstructive pulmonary disease(COPD) is known to 5.6 ~ 9.8%. Then life insurance applicants from persons with COPD are frequently encountered, and the underwriter and insurance medical doctors are called on with some regularity to render assessments of the mortality risk associated with COPD. According to previous article which contains long-term follow up of COPD, mortality ratio and excess death rate were 230% and 29 per 1000, respectively. Nowadays molecular genetic methodology such as GWAS has been developed. So it might be possible that molecular diagnostic methods may be one of useful underwriting tools in the life insurance risk selection of COPD applicants.
|
|
|
KEYWORD
|
|
|
chronic obstructive pulmonary disease, underwriting, insurance medicine
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|